Lozada, Keeran Aziel S.
HRN: 24-14-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
11/30/2023
12/07/2023
IV
9mg
Q36h
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes